Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
16.01%
0%
16.01%
6 Months
7.41%
0%
7.41%
1 Year
45.19%
0%
45.19%
2 Years
45.76%
0%
45.76%
3 Years
28.97%
0%
28.97%
4 Years
10.79%
0%
10.79%
5 Years
83.37%
0%
83.37%
Canature Health Technology Group Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.71%
EBIT Growth (5y)
7.83%
EBIT to Interest (avg)
6.62
Debt to EBITDA (avg)
0.63
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
0.78
Tax Ratio
14.34%
Dividend Payout Ratio
106.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
10.55%
ROE (avg)
9.55%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.55
EV to EBIT
11.15
EV to EBITDA
7.82
EV to Capital Employed
1.51
EV to Sales
1.19
PEG Ratio
NA
Dividend Yield
3.98%
ROCE (Latest)
13.54%
ROE (Latest)
10.38%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
466.30
424.70
9.80%
Operating Profit (PBDIT) excl Other Income
57.20
72.90
-21.54%
Interest
9.20
7.90
16.46%
Exceptional Items
0.00
0.00
Consolidate Net Profit
31.80
36.40
-12.64%
Operating Profit Margin (Excl OI)
122.60%
124.40%
-0.18%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 9.80% vs -4.75% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -12.64% vs -58.21% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,682.10
1,664.60
1.05%
Operating Profit (PBDIT) excl Other Income
239.00
233.70
2.27%
Interest
38.20
32.60
17.18%
Exceptional Items
-7.10
26.90
-126.39%
Consolidate Net Profit
113.40
153.50
-26.12%
Operating Profit Margin (Excl OI)
94.70%
92.80%
0.19%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 1.05% vs 0.60% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -26.12% vs 55.05% in Dec 2023
About Canature Health Technology Group Co., Ltd. 
Canature Health Technology Group Co., Ltd.
Industrial Manufacturing
No Details Available.
Company Coordinates 
No Company Details Available






